23 April 2019 - - US-based pharmaceutical companies Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) have received top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg, the company said.

The objective o...
23 April 2019 - - The US Food and Drug Administration has approved abbreviated new drug application No. 208024 for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray owned by Akorn, Inc. (NASDAQ: AKRX), US-based emerging commercial-stage pharma...
23 April 2019 - - Chinese biotechnology company HitGen Inc has achieved a milestone in its discovery alliance with US-based drugmaker Merck and Co. Inc., the company said.

The milestone was for the identification of candidates meeting pr...
23 April 2019 - - US-based biopharmaceutical company Arrakis Therapeutics has completed a USD 75m series B financing co-led by venBio Partners and Nextech Invest, with participation by new investors Omega Funds, HBM Healthcare Investments, GV (former...
23 April 2019 - - US-based clinical-stage immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has appointed Stanford Peng, M.D. Ph.D as president and head of research and development of Alpine, the company said.

Peng, who s...